Northwire Canada EditionTuesday, July 14, 2026
Northwire
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%
Regulatory

Zefiro founder wins partial N.Y. case dismissal

ZEFI · Price

Executive Summary

  • Zefiro Methane Corp. founder Dr. Talal Debs reports that a New York court granted in part his motion to dismiss a civil case brought by David McGrath, dismissing multiple allegations against Debs, X Machina Capital Strategies Fund I GP LLC (XMC), and X Machina Capital Strategies LP (XMST).
  • Dr. Debs comments on the results of the company's Annual General and Special Meeting of Shareholders held on March 20, 2026, noting that while he was unsuccessful in electing his slate of directors, he respects the shareholders' decision and plans to hold the board accountable.
  • Tensions remain high as Zefiro CEO Catherine Flax has filed separate litigation against XMC, prompting XMC to file a counter-suit in Florida for tortious interference, civil conspiracy, and defamation.

Key Details

  • Litigation Outcome (New York): A New York court decision delivered on March 19, 2026, dismissed multiple allegations in the civil case brought by David McGrath against Dr. Debs, XMC, and XMST. Dr. Debs remains confident he will prevail on the remaining counts.
  • Shareholder Meeting Results: The Annual General and Special Meeting of Shareholders was held on March 20, 2026. Dr. Debs was unsuccessful in his efforts to elect his slate of directors to the board.
  • Counter-Litigation (Florida): XMC has filed suit in Florida against David McGrath and Zefiro CEO Catherine Flax. Claims include tortious interference, civil conspiracy, and defamation, stemming from what Debs describes as "cynical" actions by McGrath and Flax to entrench incumbent directors.
  • Shareholder Rights: XMC retains the right to acquire additional shares representing up to 7.3% of Zefiro's outstanding shares pursuant to an investor rights agreement between Zefiro and XMST.
  • Strategic Commentary: Dr. Debs states that the proxy campaign raised awareness of governance and transparency issues, contributed to an improved balance sheet, a higher share price, and expanded strategic options. He asserts that XMC remains a significant part of the portfolio and continues to invest in energy assets.

Notable Quotes

  • "I am grateful to have had the opportunity to contribute to Zefiro as its founder, CEO and chairman over the past several years. We have established a solid foundation upon which to build an environmental services leader with exciting growth prospects."
  • "I believe the proxy campaign raised awareness of important issues in the areas of governance and transparency at Zefiro and will likely lead to improvements going forward. It also played a key role in an improved balance sheet and a higher share price and therefore expanded strategic options. These results have benefited all shareholders including XMC."
Read the original news release →

More from Zefiro Methane Corp